Detalhe da pesquisa
1.
Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses.
Mol Ther
; 26(9): 2315-2325, 2018 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30005865
2.
Oncogenic Herpesvirus Utilizes Stress-Induced Cell Cycle Checkpoints for Efficient Lytic Replication.
PLoS Pathog
; 12(2): e1005424, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26891221
3.
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.
Cancer Res Commun
; 3(7): 1260-1276, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37484198
4.
Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma.
J Clin Invest
; 133(6)2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719749
5.
Contrasting DNA damage checkpoint responses in epithelium of the human seminal vesicle and prostate.
Prostate
; 72(10): 1060-70, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22072329
6.
Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation.
Cancer Cell
; 5(5): 465-75, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15144954
7.
Non-CDK-bound p27 (p27(NCDK)) is a marker for cell stress and is regulated through the Akt/PKB and AMPK-kinase pathways.
Exp Cell Res
; 316(5): 762-74, 2010 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20036235
8.
Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy.
Cancers (Basel)
; 13(14)2021 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34298622
9.
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma.
Cancer Immunol Res
; 9(8): 981-993, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34103348
10.
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification.
ACS Nano
; 15(10): 15992-16010, 2021 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605646
11.
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy.
Cancer Res
; 80(12): 2575-2585, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107211
12.
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy.
PLoS One
; 14(10): e0224072, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31644552
13.
Artificially cloaked viral nanovaccine for cancer immunotherapy.
Nat Commun
; 10(1): 5747, 2019 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31848338
14.
KIT overexpression induces proliferation in astrocytes in an imatinib-responsive manner and associates with proliferation index in gliomas.
Int J Cancer
; 123(4): 793-800, 2008 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18506689
15.
Small-Molecule Targeting of RNA Polymerase I Activates a Conserved Transcription Elongation Checkpoint.
Cell Rep
; 23(2): 404-414, 2018 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29642000
16.
Severe neurodegenerative disease in brothers with homozygous mutation in POLR1A.
Eur J Hum Genet
; 25(3): 315-323, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28051070
17.
Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277.
Nucleic Acids Res
; 30(11): 2340-8, 2002 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12034820
18.
Small molecule BMH-compounds that inhibit RNA polymerase I and cause nucleolar stress.
Mol Cancer Ther
; 13(11): 2537-46, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25277384
19.
DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response.
Oncotarget
; 5(12): 4361-9, 2014 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24952786
20.
A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.
Cancer Cell
; 25(1): 77-90, 2014 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24434211